References
- Giinthard J, Stocker F, Bolz D, Jäggi E, Ghisla R, Ober-hänsli I, Wyler F. Dilated cardiomyopathy and thrombo-embolism. Eur J Pediatr 1997; 156: 3–6.
- Gottdiener JS, Gay JA, Van Voorhees L, DiBianco R, Fletcher RD. Frequency and embolic potential of left ven-tricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. Am J Cardiol 1983; 52: 1281-5.
- Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J 1992; 123: 136–42.
- Choi SH, Jeong SI, Yang JH, Kang IS, Jun TG, Lee HJ, Huh J. A single-center experience with intracardiac throm-bosis in childrenwith dilated cardiomyopathy. Pediatr Car-diol 2010; 31: 264–9.
- Buchalter M, Bourke JP, Tansuphaswadikul S. Unusual echocardiographic appearance of intracardiac thrombi in a patient with endomyocardial fibrosis. Br Heart J 1987; 57: 300.
- Lavi N, Zelinger A, Silver M. Thrombotic “ghosts”: echocar-diographic appearance of thrombi with hollow cores and implications regarding mechanism of spontaneous clot lysis. J Am Soc Echocardiogr 2006; 19: 1530.e5–e6.
- Lucas MA, Fretto IA McKee PA. The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem 1983; 258: 4249–56.
- Bouma BN, Meijers JCM. Thrombin-activatable fibrinolysis inhibitor (TAFT), plasma procarboxypeptidase B, procarbo-xypeptidase R, procarboxypeptidase U. J Thromb Haemost 2003; 1: 1566–74.
- Schneider M, Nesheim M. A study of the protection of plas-min from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis. J Biol Chem 2004; 279: 13333–9.
- Moir E, Booth NA, Bennett B, Robbie LA. Polymorphonu-clear leucocytes mediate endogenous thrombus lysis via u-PA dependent mechanism. Br J Haematol 2001; 113: 72–80.